GI-Bleeding Prophylaxis Benefits Higher-Risk Critically Ill Patients GI-Bleeding Prophylaxis Benefits Higher-Risk Critically Ill Patients

Prophylaxis with proton-pump inhibitors (PPIs) or histamine-2-receptor antagonists (H2RAs) significantly reduces gastrointestinal bleeding in higher-risk critically ill patients, but not in patients at low risk of bleeding, according to a systematic review and network meta-analysis.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Gastroenterology News Source Type: news